DM Drug Development & Approval Considerations with the FDA - 2023 MDF Annual Conference

Presented on September 8th, 2023.
Gain insight and understanding on the important role the FDA plays in the drug approval process through a presentation from the FDA. This informative presentation will be followed by a panel discussion with the FDA, a DM expert clinician, and members of the DM Community. This session provides an opportunity for our community and clinicians to share the serious medical challenges facing our community with the FDA.
Speakers include:
- Nicholas Johnson, MD, MSci., FAAN, Virginia Commonwealth
University
- Michelle Campbell, PhD, Federal Drug Administration
- Ami K. Mankodi, MD, Federal Drug Administration
- Kevin Brennan, MDF Advocacy Consultant
- Mark Planco
- Haley Martinelli
- Jeannine DeSoi
Chapters
0:00:00 - Introduction
0:06:04 - Michelle Campbell, PhD
0:35:31 - Nicholas Johnson, MD, MSci., FAAN
0:46:40 - Panelist Introductions
0:47:47 - Mark Planco
0:56:26 - Haley Martinelli
1:03:40 - Jeannine DeSoi
1:20:44 - Thank You & Closing